Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Prospective Study to Evaluate Effectiveness of Subcutaneous Treatment With Foslevodopa/Foscarbidopa in Real Life Setting for Advanced Parkinson's Disease Patients in Belgium.

NCT07382440 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT07382440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07382440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Prospective Study to Evaluate Effectiveness of Subcutaneous Treatment With Foslevodopa/Foscarbidopa in Real Life Setting for Advanced Parkinson's Disease Patients in Belgium.
Lead sponsor
AbbVie
Phase
Observational
Overall status
Recruiting
Start date
March 9, 2026
Completion date
September 30, 2028
Enrollment
120 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease